Skip to main content
TipRanks
Go Ultimate75% OFF

Biora Therapeutics (BIORQ) Drug Pipeline

1,085 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Bt-600HealthyPhase ICompletedBT-600 Single and Multiple Ascending Oral Doses in Healthy Adult SubjectsFeb 08, 2024―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biora Therapeutics Inc. (BIORQ) have in its pipeline
Biora Therapeutics BIORQ is currently developing the following drugs: Bt-600. These drug candidates are in various stages of clinical development as the company works toward FDA approval.